Fri.May 03, 2024

Remove documentation-drug-pricing
article thumbnail

NICE recommends new haemolytic anaemia treatment

European Pharmaceutical Review

The document also detailed that clinical evidence has shown that patients given voxelotor “are more likely to have an increase in haemoglobin levels compared with people who have usual treatment”. NICE’s decision follows a reduction in the price of voxelotor.